Blue Medical Devices

Blue Medical Devices is a Dutch medical device company specializing in interventional cardiology. Founded in 1998 and based in Helmond, Netherlands, the company develops and manufactures innovative balloon catheters, including drug-coated balloons (DCB) and other specialty balloons for complex coronary interventions. Its flagship products include the Protégé and Protégé NC paclitaxel-coated coronary balloon dilatation catheters, which utilize a patented drug application technology to minimize drug loss during device advancement. In June 2023, Blue Medical Devices was acquired by Translumina, a global interventional cardiovascular device company backed by Everstone Capital, and now serves as a key manufacturing and R&D hub within Translumina's global network.